Evidence map›Paper›PMID 34678063›Full record

ArticleScience advances2021

Structural basis for selective modification of Rho and Ras GTPases by

Zheng Liu, Sicai Zhang, Peng Chen, Songhai Tian, Ji Zeng, Kay Perry, Min Dong, Rongsheng Jin

Abstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. AgainstToxins · 2025
    Review
  7. Comprehensive review ofWorld journal of gastrointestinal pharmacology and therapeutics · 2025
    Article
  8. Mechanisms ofFrontiers in cellular and infection microbiology · 2025
    Review
  9. Article
  10. Toxins · 2024
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. ACS chemical biology · 2022
    Article
  16. Structure and conformational dynamics ofLife science alliance · 2022
    Article
  17. Article
  18. TcdB ofInternational journal of molecular sciences · 2022
    Article
  19. Neutralizing epitopes onFrontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zheng LiuDepartment of Physiology and Biophysics, University of California, Irvine, Irvine, CA 92697, USA.ORCID 0000-0002-6842-6273
Sicai ZhangDepartment of Urology, Boston Children's Hospital, and Departments of Microbiology and Surgery, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-8894-5476
Peng ChenDepartment of Physiology and Biophysics, University of California, Irvine, Irvine, CA 92697, USA.ORCID 0000-0002-6356-7683
Songhai TianDepartment of Urology, Boston Children's Hospital, and Departments of Microbiology and Surgery, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-6630-1904
Ji ZengDepartment of Urology, Boston Children's Hospital, and Departments of Microbiology and Surgery, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-8770-3048
Kay PerryNE-CAT and Department of Chemistry and Chemical Biology, Cornell University, Argonne National Laboratory, Lemont, IL 60439, USA.ORCID 0000-0002-4046-1704
Min DongDepartment of Urology, Boston Children's Hospital, and Departments of Microbiology and Surgery, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-1744-7293
Rongsheng JinDepartment of Physiology and Biophysics, University of California, Irvine, Irvine, CA 92697, USA.ORCID 0000-0003-0348-7363

Funding

User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI MALCOLM S. CAPEL · 2018 to 2026
$34.2M
Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
Structure and Function of C. Difficile ToxinsR01AI139087 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI Min Dong, Rongsheng Jin · 2018 to 2026
$7.4M
Long-term effects of botulinum neurotoxins on neuronal viabilityR01NS080833 · NINDS · HARVARD MEDICAL SCHOOL · PI Min Dong · 2013 to 2026
$6.8M
Molecular basis of action and pathogenesis of Clostridium difficile toxin BR01AI132387 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI DONG, MIN · 2017 to 2021
$3.5M
Molecular mechanisms of botulinum neurotoxin neutralizationR01AI125704 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI JIN, RONGSHENG, SHOEMAKER, CHARLES BIX · 2016 to 2020
$3.0M
Pixel Array Detector for Macromolecular CrystallographyS10OD021527 · OD · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2016 to 2016
$2.0M
Computational design of inhibitors against botulinum neurotoxinR21AI139690 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI JIN, RONGSHENG · 2018 to 2019
$440k
Structural basis of Rho glucosylation by Clostridium difficile toxinsR21AI156092 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI JIN, RONGSHENG · 2021 to 2022
$432k
Structural mechanism for recognition of host receptor by botulinum neurotoxin AR21AI123920 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI JIN, RONGSHENG · 2016 to 2017
$425k
Novel anti-cancer biologics targeting Wnt signaling pathwayR21CA235533 · NCI · BOSTON CHILDREN'S HOSPITAL · PI DONG, MIN, JIN, RONGSHENG · 2019 to 2020
$413k
NCI NIH HHS R21 CA235533NIAID NIH HHS R01 AI125704NIAID NIH HHS R01 AI132387NIAID NIH HHS R01 AI139087NIAID NIH HHS R21 AI123920NIAID NIH HHS R21 AI139690NIAID NIH HHS R21 AI156092NICHD NIH HHS P50 HD105351NIGMS NIH HHS P30 GM124165NIH HHS S10 OD021527NINDS NIH HHS R01 NS080833
6 · The paper itself

Abstract

Toxin B (TcdB) is a primary cause of

Identifiers

PMID34678063
PMCPMC8535798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.